VIRGINIA BOURDEAU: Open Payments
NPI 1407031289 · RENSSELAER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 18 payments from 10 companies in 2025. Trend: 2023 $440 · 2024 $295 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $88 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| ABBVIE INC. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Exact Sciences Corporation | 2 | $38 |
| Amgen Inc. | 2 | $31 |
| Seqirus USA Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Edwards Lifesciences Corporation | 1 | $20 |
| PFIZER INC. | 1 | $14 |
Products named: Wegovy, LEQVIO, The Cologuard Plus Collection Kit, OTEZLA, Fluad, SYNTHROID, BEXSERO, MOUNJARO.
Industry payments across NY — which companies pay providers there.
